Vergoeding 2017-2021 per ATC-hoofdgroep C : Hartvaatstelsel
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| C01 Cardiaca | 28.435.900 | 27.523.100 | 25.842.800 | 25.056.300 | 23.921.200 |
| C02 Antihypertensiva | 39.535.900 | 40.809.200 | 37.934.900 | 39.283.300 | 36.773.200 |
| C03 Diuretica | 17.430.900 | 18.716.300 | 22.857.100 | 24.586.700 | 26.741.900 |
| C04 Perifere vasodilatantia | 132.790 | 122.100 | 109.830 | 105.780 | 97.200 |
| C05 Vasoprotectiva | 1.030.600 | 1.053.900 | 1.061.400 | 1.025.100 | 1.264.800 |
| C07 Beta-blokkers | 25.608.500 | 25.964.000 | 27.548.900 | 28.600.700 | 33.875.300 |
| C08 Calciumantagonisten | 33.463.900 | 34.127.000 | 36.618.200 | 37.816.100 | 39.163.300 |
| C09 Middelen aangrijpend op het renine-angiotensinesysteem | 48.418.300 | 51.271.000 | 63.573.300 | 69.319.300 | 76.972.900 |
| C10 Antilipaemica | 180.920.200 | 143.877.100 | 125.646.000 | 139.927.600 | 148.631.700 |
| Totaal | 374.976.990 | 343.463.700 | 341.192.430 | 365.720.880 | 387.441.500 |